Review: taking Zofran and Dramamine together


Summary

Drug interactions are reported among people who take Zofran and Dramamine together. This review analyzes the effectiveness and drug interactions between Zofran and Dramamine. It is created by eHealthMe based on reports of 318 people who take the same drugs from FDA and social media, and is updated regularly.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Zofran

Zofran has active ingredients of ondansetron hydrochloride. It is often used in nausea. (latest outcomes from Zofran 36,472 users)

Dramamine

Dramamine has active ingredients of dimenhydrinate. It is often used in nausea. (latest outcomes from Dramamine 578 users)

On Sep, 16, 2016

318 people who take Zofran, Dramamine are studied.


Number of reports submitted per year:

Zofran and Dramamine drug interactions.

Drug effectiveness over time:

Zofran:
  • < 1 month: 0.0% - (0 of 1 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 1 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Dramamine:
  • < 1 month: 0.0% - (0 of 2 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Zofran:
  • female: 0.0% - (0 of 1 people)
  • male: 0.0% - (0 of 1 people)
Dramamine:
  • female: 0.0% - (0 of 1 people)
  • male: 0.0% - (0 of 1 people)

Drug effectiveness by age:

Zofran:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 1 people)
  • 30-39: 0.0% - (0 of 1 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 0 people)
Dramamine:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 1 people)
  • 30-39: 0.0% - (0 of 1 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 0 people)

Most common drug interactions over time *:

< 1 month:
  • febrile neutropenia
  • nausea
  • fatigue
  • oxygen saturation decreased
  • atelectasis
  • cardiomegaly
  • convulsion
  • pneumothorax
  • respiratory distress
  • anaemia
1 - 6 months:
  • epistaxis
  • hypotension
  • leukopenia
  • renal failure
  • thrombocytopenia
  • arthralgia
  • cellulitis
  • cholestasis
  • dehydration
  • cerebral infarction
1 - 2 years:
  • acute myeloid leukaemia
  • cardiac failure congestive
  • cholestasis
  • disease progression
  • ejection fraction decreased
  • lethargy
  • mucosal inflammation
  • oedema
not specified:
  • nausea
  • vomiting
  • diarrhoea
  • ventricular tachycardia
  • pain in extremity
  • abdominal pain
  • fatigue
  • dehydration
  • headache
  • pyrexia

Most common drug interactions by gender *:

female:
  • nausea
  • vomiting
  • febrile neutropenia
  • ventricular tachycardia
  • dehydration
  • headache
  • asthenia
  • diarrhoea
  • acute pulmonary oedema
  • fatigue
male:
  • nausea
  • vomiting
  • atelectasis
  • cardiomegaly
  • respiratory distress
  • convulsion
  • oxygen saturation decreased
  • pneumothorax
  • diarrhoea
  • fatigue

Most common drug interactions by age *:

2-9:
  • dyskinesia
  • movement disorder
  • excessive eye blinking
  • eyelid ptosis
  • gait disturbance
  • pain in extremity
  • abdominal pain
  • alanine aminotransferase increased
  • aspartate aminotransferase increased
  • diarrhoea
10-19:
  • ventricular tachycardia
  • thrombocytopenia
  • leukopenia
  • drug clearance decreased
  • nausea
  • pain in extremity
  • ventricular extrasystoles
  • electrocardiogram qt prolonged
  • neuropathy peripheral
  • vomiting
20-29:
  • colitis ulcerative
  • blood alkaline phosphatase increased
  • blood creatinine increased
  • gamma-glutamyltransferase increased
  • hepatic enzyme increased
  • nausea
  • pyrexia
  • rash
  • abdominal pain
  • abdominal pain upper
30-39:
  • atelectasis
  • cardiomegaly
  • convulsion
  • oxygen saturation decreased
  • pneumothorax
  • respiratory distress
  • blood pressure increased
  • pain
  • blood potassium decreased
  • bronchopleural fistula
40-49:
  • nausea
  • blood potassium increased
  • blood sodium decreased
  • fatigue
  • hyperglycaemia
  • vomiting
  • nephritic syndrome
  • dry mouth
  • blood chloride decreased
  • diarrhoea
50-59:
  • diarrhoea
  • fatigue
  • febrile neutropenia
  • pleural effusion
  • abdominal pain
  • dehydration
  • depressed level of consciousness
  • nausea
  • vomiting
  • anaemia
60+:
  • nausea
  • vomiting
  • general physical health deterioration
  • febrile neutropenia
  • dehydration
  • pulmonary embolism
  • atrial fibrillation
  • pyrexia
  • neutropenia
  • rapid correction of hyponatraemia

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Zofran and Dramamine?


Recent conversations of related support groups:

Can you answer these questions?

More questions for: Zofran, Dramamine

You may be interested in these reviews

More reviews for: Zofran, Dramamine

On eHealthMe, Zofran (ondansetron hydrochloride) is often used to treat nausea. Dramamine (dimenhydrinate) is often used to treat nausea. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.